Tovar v. Essentia Health

187 F. Supp. 3d 1055, 61 Employee Benefits Cas. (BNA) 2901, 2016 U.S. Dist. LEXIS 62529, 2016 WL 2745816
CourtDistrict Court, D. Minnesota
DecidedMay 11, 2016
DocketCiv. No. 16-100 (RHK/LIB)
StatusPublished
Cited by1 cases

This text of 187 F. Supp. 3d 1055 (Tovar v. Essentia Health) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tovar v. Essentia Health, 187 F. Supp. 3d 1055, 61 Employee Benefits Cas. (BNA) 2901, 2016 U.S. Dist. LEXIS 62529, 2016 WL 2745816 (mnd 2016).

Opinion

MEMORANDUM OPINION AND ORDER

RICHARD H. KYLE, United States District Judge

INTRODUCTION

Plaintiff Brittany Tovar commenced this action after her son, a beneficiary under her employer-sponsored health insurance policy, was denied coverage for gender reassignment services and surgery. She alleges her employer, Defendants Essentia Health and Innovis Health, LLC, d/b/a Essentia Health West (collectively, “Es-sentia”),1 violated Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq. (“Title VII”), and the Minnesota Human Rights Act, Minn. Stat. § 363A.01 et seq. (“MHRA”), by excluding coverage for gender reassignment services or surgery in Essentia’s employee medical plan. She also alleges Defendant HealthPartners, Inc. (“HealthPartners”) violated Section 1557 of the Affordable Care Act, 42 U.S.C. § 18116 (“ACA”), by administering Essen-tia’s plan and enforcing the exclusion. Defendants move to dismiss Tovar’s claims; for the reasons that follow, their Motions will be granted.

BACKGROUND

Tovar is a nurse practitioner employed by Essentia since 2010. (Compl. ¶ 21.) As part of her employee benefits, she is provided health insurance through the Essen-tia Health Employee Medical Plan (the “Plan”), which is sponsored by Essentia and administered by HealthPartners.2 (Id. [1057]*1057¶¶ 7, 22-24.) In late 2014, Tovar’s teenage son became a beneficiary under the Plan and was subsequently diagnosed with gender dysphoria.3 (Id ¶¶ 26-27.)

At issue in this case is the 2015 version of the Plan (the “2015 Plan”), which barred coverage for “services and/or surgery for gender reassignment.” (Id. ¶25; see also Bunde Decl. Ex. A4 at 51.) Due to this exclusion, Tovar’s son was denied coverage for certain medications and gender reassignment surgery that were deemed medically necessary by his doctors. (Compl. ¶¶ 30-31.) Tovar’s Complaint cites three specific incidents where her son was denied coverage:

1. In 2015, he was prescribed the drug Lupron, which is recommended for treatment of symptoms associated with dysmenorrhea (painful menstruation) and can temporarily suspend menstruation; the latter being why Tovar’s son was prescribed the drug. (Id. ¶¶ 35-37.) But because the 2015 Plan excluded services for gender reassignment, the Lupron prescription was not covered and would have cost approximately $9,000. (Id. ¶¶ 38, 40.) Tovar was unable to afford this and her son did not receive Lupron. (Id. ¶ 40.)
2. Tovar’s son was also prescribed An-droderm, a form of testosterone, to treat his gender dysphoria. (Id. ¶ 42.) Coverage also was .denied for this prescription because the medicine was “for use by males only” and was “not covered for patient gender.” (Id. ¶ 43.) However, Tovar did pay out-of-pocket for this prescription and “Es-sentía later agreed” to cover the medicine as a one-time exception. (Id. ¶¶ 44-45.).
3.In December 2015, Tovar contacted HealthPartners seeking pre-authori-zation for gender reassignment surgery for her son; she was notified it would not be authorized because of the exclusion in the 2015 Plan. (Id. ¶ 46.)

Tovar alleges that, because her son was unable to obtain these necessary medical services, she suffered from stress, worry, anger, disappointment, and sleeplessness, experienced an increase in migraines, and ultimately reduced her hours at work. (Id. ¶¶ 41, 48.)

Effective January 1, 2016, the Plan was amended (the “2016 Plan”) and the exclusion for gender-reassignment services and surgery was removed. (Bunde Decl. Ex. E at Amendment.) The 2016 Plan remains self-insured and sponsored by Essentia. (Id. at 22-23.)

Tovar commenced this action on January 15, 2016, -alleging sex discrimination against Essentia in violation of Title VII and the MHRA (Counts I and II, respectively) and against HealthPartners in violation of the ACA (Count III). For the economical and emotional harm she allegedly suffered due to this “discrimination,” she seeks compensatory damages, as well as declaratory and injunctive relief.

HealthPartners now moves to dismiss for lack of subject-matter jurisdiction and Essentia moves to dismiss for failure to state a claim. Defendants raise two issues with Tovar’s Complaint. HealthPartners argues Tovar does not have standing to [1058]*1058assert her claims against it because a separate entity, HealthPartners Administrators, Inc. (“HPAI”), is actually the third-party administrator (“TPA”) of Essentia’s self-insured Plan. Essentia argues that To-var lacks statutory standing and thus fails to state a claim upon which relief can be granted. The Motions have been fully briefed, the Court heard oral argument on April 14, 2016, and the Motions are ripe for disposition,

I. Subject-matter jurisdiction (Rule 12(b)(1))

a. Standard of decision

It is a plaintiffs burden to establish that jurisdiction exists. Osborn v. United States, 918 F.2d 724, 730 (8th Cir.1990). In deciding a motion to dismiss for lack of subject-matter jurisdiction, the Court is “free to- weigh the evidence and satisfy itself as to the existence of its power to hear the case.” Id. There are two methods of challenging whether subject-matter jurisdiction exists: a facial attack, which challenges the plaintiffs allegations within the Complaint, Stalley v. Catholic Health Initiatives, 509 F.3d 517, 520-21 (8th Cir.2007), and a factual attack, which looks to matters beyond the pleadings to resolve facts and determine jurisdiction, Osborn, 918 F.2d at 729 n. 6. Here, HealthPartners has mounted a factual attack because its argument is based on matters outside the pleadings, namely, the 2015 Plan (Bunde Deck Ex. A) and the 2016 Plan (id. Ex. E).

b. Analysis

HealthPartners argues Tovar does not have standing to sue it because her injuries are not “fairly traceable” to its conduct; the TPA of the 2015 Plan is actually HPAI. (HealthPartners Mem. at 2 n.l.) The 2015 Plan, which Tovar agrees is properly before the Court, explicitly lists HPAI as the TPA. (See Bunde Decl. Ex. A. at 22-23.) The 2016 Plan states the same. (Id. Ex. E at 22-23.)

This highlights why Tovar’s third count against HealthPartners fails for lack of standing. She alleges that HealthPartners discriminated against her in violation of the ACA5 “by serving as the [TPA] for the Essentia Health Employee Medical Plan and enforcing the Plan’s discriminatory exclusion of any ‘services and/or surgery for gender reassignment.’ ” (Compl. ¶ 63.) But, HealthPartners plainly was not the administrator of either the 2015 or 2016 Plan. The parties agree that to satisfy Article Ill’s standing requirements, Tovar must show (1) she has suffered an injury-in-fact that is (a) concrete and particularized and (b) actual or imminent, not conjectural or hypothetical; (2) the injury is fairly traceable

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Askari v. Taj and Ark, LLC
D. New Mexico, 2025

Cite This Page — Counsel Stack

Bluebook (online)
187 F. Supp. 3d 1055, 61 Employee Benefits Cas. (BNA) 2901, 2016 U.S. Dist. LEXIS 62529, 2016 WL 2745816, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tovar-v-essentia-health-mnd-2016.